A Randomized, Crossover, Placebo Controlled, Double-blind Trial of the Effect of STIOLTO RESPIMAT on Central and Peripheral Components of Fatigue During Exercise in Chronic Obstructive Pulmonary Disease

Next Previous
Trial Profile

A Randomized, Crossover, Placebo Controlled, Double-blind Trial of the Effect of STIOLTO RESPIMAT on Central and Peripheral Components of Fatigue During Exercise in Chronic Obstructive Pulmonary Disease

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Aug 2017

At a glance

  • Drugs Olodaterol/tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease; Fatigue
  • Focus Therapeutic Use

    • Most Recent Events

    • 16 Aug 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
    • 16 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
    • 16 Aug 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top